er vo ric ear HER2, and proliferation. Adjuvant endocrine therapy for a minimum of five years postoperatively is advised to pa-differ molecularly, in prognosis as well as relapse rates after different therapy modalities [4]. The two lumina

Similar works

Full text

oai:CiteSeerX.psu: time updated on 10/30/2017

This paper was published in CiteSeerX.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.